Preclinical investigations

Mouse in laboratory
#Clinical trials #Drug toxicity #Mouse models #Pharmacology #Preclinical investigations #Whitepaper

Whitepaper: Ensure accurate dose prediction for clinical trials

Accurate dose prediction for clinical trials is essential to ensure patient safety and trial success. This new whitepaper from the Jackson Laboratory discusses evidence-based selection of starting doses in first-in-human clinical trials through the utilisation of humanised mouse models. In this whitepaper you will learn about: The significance… Read More

#News

#Clinical trials #Drug toxicity #Mouse models #Pharmacology #Preclinical investigations

Discover evidence-based, first-in-human dose selection

This whitepaper discusses evidence-based selection of starting doses in first-in-human clinical trials through the utilisation of humanised mouse models and emphasises the importance of accurate dose prediction to ensure patient safety and trial success. In this whitepaper you will learn about: The significance of selecting appropriate starting doses in clinical… Read More

#Resources

Pluripotent stem cells
#Human disease models #iPSC #Liver disease #Preclinical investigations #Stem cells #Webinar

How do iPSC derived cells support development of gene therapies?

A considerable roadblock in the successful triaging of new therapeutics for liver and metabolic related diseases is the reliability and effectiveness of pre-clinical disease models. Methods employing animal models may have limited success in replicating liver diseases, primarily because of species-specific differences, furthermore, the utilisation of animal models… Read More

Webinar date:
Supported by DefiniGEN
#News

Pluripotent stem cells
#Human disease models #iPSC #Liver disease #Preclinical investigations #Stem cells #Webinar

Discover how iPSC derived cells can be used to support the development of drug and gene therapies

A considerable roadblock in the successful triaging of new therapeutics for liver and metabolic related diseases is the reliability and effectiveness of pre-clinical disease models. Methods employing animal models may have limited success in replicating liver diseases, primarily because of species-specific differences, furthermore, the utilisation of animal models to simulate… Read More

Webinar date:
Supported by DefiniGEN
#Webinars

Covid-19
#Antivirals #Covid-19 #Covid-19 treatment #Infex Therapeutics #Preclinical investigations

New antiviral potential solution to resistant Covid-19 variants

In preclinical studies, a new pan-coronavirus papain-like protease (PLpro) inhibitor has shown a near complete reduction in SARS-CoV-2 viral load in the lungs. Infex Therapeutics has selected the clinical candidate for its in-house COV-X programme based on this in vivoefficacy data in a murine SARS-CoV-2 model. Read More

#News #Trending News

Human brain
#AlzeCure Pharma #Antidepressants #Depression #Preclinical investigations #Psychiatry

Preclinical study proves antidepressant effects of drug

The results of a preclinical study supporting the antidepressive effects of AlzeCure Pharma’s NeuroRestore ACD856 have been published in the journal Psychopharmacology. The article focuses on new data showing that ACD856, the lead and clinical drug candidate in the NeuroRestore platform, exhibits antidepressant effects in various… Read More

#Editor's Choice #News

#Drug development #Drug discovery #Guide #Mouse models #Oncology #Preclinical investigations #TransCure bioServices

Unlock the full potential of your preclinical oncology studies

With an attrition rate of up to 95% for oncology drug development, it is evident that significant barriers still exist when it comes to translating preclinical investigation findings to in-human trials. This new Guide from TransCure bioServices explores how humanized mouse models can help accelerate the successful development… Read More

#News

#Drug development #Drug discovery #Guide #Mouse models #Oncology #Preclinical investigations

Unlock the full potential of your preclinical oncology studies with a humanized mouse model

With an attrition rate of up to 95% for oncology drug development, it is evident that significant barriers still exist when it comes to translating preclinical investigation findings to in-human trials. Our Guide explores how humanized mouse models can help accelerate the successful development of novel, safe, and effective treatments… Read More

#Intelligence #Resources

Osteoarthritis
#Link Biologics #Osteoarthritis #Preclinical investigations #The University of Manchester

Research reveals promising novel treatment for osteoarthritis

Researchers from the University of Manchester and Link Biologics have revealed preclinical data on a potential new treatment for osteoarthritis. The results were published in a paper in journal Osteoarthritis and Cartilage, which describes the development of a protein biological drug termed Link_TSG6 with disease modifying… Read More

#Editor's Choice #News

Back pain
#Chemical engineering #Mouse models #Painkillers #Preclinical investigations

Researchers modify anti-nausea drug to treat pain

Altering the chemical properties of an anti-nausea drug enables it to enter an interior compartment of the cell and provide long-lasting pain relief, according to a new study led by researchers at NYU College of Dentistry’s Pain Research Center. The study, published in the Proceedings of… Read More

#News

Amygdala
#Anxiety disorder #Drug discovery #Neuroscience #Preclinical investigations #University of Bristol #University of Exeter

Discovery represents the ‘first step’ to better anti-anxiety drugs

A team of scientists have discovered that modification of a gene in the brain can reduce anxiety levels, offering an exciting novel drug target for anxiety disorders. The discovery, led by researchers at the Universities of Bristol and Exeter in the UK, is published in Nature… Read More

#News

Natural killer cells
#Cancer research #Icahn School of Medicine #Lung cancer #Macrophages #Oncology #Preclinical investigations

Macrophages suppress natural killer cells in lung cancer tumours

Researchers at the Icahn School of Medicine at Mount Sinai have demonstrated in a preclinical study a potential new therapeutic approach to treating the most common form of lung cancer. The strategy involves inhibiting the immune-system molecule TREM2 while enhancing natural killer cells. “Our… Read More

#Cancer Research #News

Animal testing
#Animal models #Animal testing #Cellular assays #FDA #Organoids #Preclinical investigations

FDA Modernization Act 2.0: A step in the right direction

By DDW Editor Reece Armstrong A lot has already been said about the US Food and Drug Administration’s (FDA) Modernization Act 2.0 and for good reason. The decision by the Biden administration to end the federal requirement for drugs under development to be tested on animals represents a significant step forward for the… Read More

#Exclusive Content

Gelatin biomaterials
#Animal testing #Biomaterials #In vitro #Preclinical investigations #Rousselot Biomedical

Low endotoxin biomaterials could help to reduce animal testing

A new study has found that highly purified gelatin biomaterials could enhance the reliability and reproducibility of 3AD in vitro models, creating new possibilities for replacing preclinical animal trials. The joint study by the University of Twente, The Netherlands, and Rousselot Biomedical investigated for the first… Read More

#News

#Animal models #Cancer research #Drug discovery #Immune response #Long Covid #mRNA #Oncology #Preclinical investigations

Weekly drug discovery highlights podcast: Listen now

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  In the news this week, we have covered a number of early-stage studies that could… Read More

#News

#Animal models #Cancer research #Drug discovery #Immune response #Long Covid #mRNA #Oncology #Preclinical investigations

This week in drug discovery (13-17 March)

News round-up for 13-17 March by DDW Digital Content Editor Diana Spencer.  In the news this week we have covered a number of early-stage studies that could lead to potentially huge breakthroughs in the treatment of metastatic breast cancer, long Covid, bacterial diseases, bone cancer, and autoimmune… Read More

#News